Ummid Assistant

Applications open for Manmohan scholarship at Cambridge

Opportunities for Indian students in US

Welcome Guest! You are here: Home National

Health experts laud SC ruling on Novartis

Monday April 01, 2013 10:50:19 PM, IANS

Related Article

SC rejects patent protection for Novartis cancer drug

The apex court bench of Justices Aftab Alam and Ranjana Prakash Desai dismissed with cost Novartis' plea challenging  

SC to decide pharma patent, take up marines case

I

New Delhi: The Supreme Court's rejection of Swiss drug maker Novartis' patent on a cancer drug was Monday hailed by health experts, who felt that it will help patients continue to get cheap generic drugs not only in India but also abroad.

"This is a huge relief for the millions of patients and doctors in developing countries who depend on affordable medicines from India, and for treatment providers like us," said Unni Karunakara, president of Medicine Sans Frontiers.

"The Supreme Court's decision now makes patents on the medicines that we desperately need less likely. This marks the strongest possible signal to Novartis and other multinational pharmaceutical companies that they should stop seeking to attack the Indian patent law," she said.

Indian generic medicines are exported to other developing countries also.

Novartis first took the Indian government to court in 2006 over its 2005 Patents Act because it wanted a more extensive granting of patent protection for its products than offered by Indian law.

Y.K. Sapru, of the Mumbai-based Cancer Patients Aid Association told IANS: "This is a landmark judgement. This will have a long time effect, as the generic version makes it affordable to poor people. Now the prices of life-saving drugs will be reduced from Rs.160,000 per month to just Rs.6,000 per month".

P.K. Julka, a professor of oncology at AIIMS, said: "The ruling is good for the poor patients. It will ensure continued access to cheap drugs."

Harsh Dua, senior consultant oncologist at the Indraprastha Apollo hospitals said: "Many patients are on generic drugs now. The medicines are already available."

"Via this judgement, the apex court has ensured that the drugs will continue to be available," he said.

Anand Grover, the lawyer representing Indian companies said: "We are very happy that the SC has rejected attempts by Novartis to water down our patent laws. They wanted patents to be granted on innovations which were really not innovations."

Indian Pharma Association's secretary general D.G Shah said: "Indian patent regime was notified in 2005, so it is not that the big companies do not know about it. They should value the market in India".
 






 

 

 




 

Home | Top of the Page

Comments

Note: By posting your comments here you agree to the terms and conditions of www.ummid.com

Comments powered by DISQUS

i

More Headlines

Jordan, Palestine ink deal to defend Jerusalem

New edition of IPL kicks off Tuesday in the city of soccer

Traders to oppose local bodies tax in Supreme Court

100-year-old retired colonel is Indian Army's First Citizen

Two Pakistani ex-lawmakers indicted in fake degree case

Petrol rates cut by 85 paise a litre from Tuesday

Four arrested for BSP leader's murder

British pupils plot gang crimes, smoke, bully teachers

Medical entrance test discriminatory for NRIs: Indian community bodies

India doing excellent in space programmes: Sunita Williams

M.F. Farooqui takes charge as Telecom Secretary

 

Top Stories

Expatriate exposes pathetic condition of Indian Muslims living in Middle East

They are no better than their counterparts back home, he says, wants from the govt. to rip off their NRI status

With the news that Saudi Arabia has started implementing its new labour law reserving 10 percent of jobs for locals consequently  

Indians in Middle East remit home over $35 billion every year

NRI deposits in Kerala stands at Rs.62,708 crore

 

  Most Read

SC rejects patent protection for Novartis cancer drug

The apex court bench of Justices Aftab Alam and Ranjana Prakash Desai dismissed with cost Novartis' plea challenging  

SC to decide pharma patent, take up marines case

Train travel to be costlier from Monday

Travelling in trains will become costlier from Monday as the hike in reservation, tatkal, cancellation fees and some other charges announced in the rail budget will come into effect. According to railway ministry, reservation fee for AC classes will go up by Rs.15 to 25 per ticket while reservation fee for second and sleeper class  

 

  News Pick

M.F. Farooqui takes charge as Telecom Secretary

Senior IAS officer of Tamil Nadu cadre M.F. Farooqui on Monday took charge as Telecom Secretary. Prior to his new posting, Farooqui was Secretary in the  

After 50 years, private dailies published in Myanmar

Four private daily newspapers started temporary publication Monday, signifying the re-introduction of private daily newspapers in the Southeast Asian nation after a gap of five decades. The four daily newspapers  

Train travel to be costlier from Monday

Travelling in trains will become costlier from Monday as the hike in reservation, tatkal, cancellation fees and some other charges announced in the rail budget will come into effect. According to railway ministry, reservation  

JIH denies allegations against its girls' wing

Intelligence agencies in Maharashtra have sent letters to all police stations in Mumbai asking them to monitor the activities of the Girls Islamic Organization (GIO). The organization is trying to "motivate girls towards Islam", the letter    

 

Picture of the Day

President of India Pranab Mukherjee released a Commemorative Postage Stamp on Late Yashwantrao Chavan, at the concluding ceremony of the birth centenary celebration of former CM of Maharashtra, Late Yashwantrao Chavan, in Mumbai on March 23, 2013. Union Minister for Agriculture and Food Processing Industries Sharad Pawar is also seen.

 

Recommend the story to your friends

 

 
 
 
 
 
 
 
 

RSS  |  Contact us

 

| Quick links

News

 

Subscribe to

Ummid Assistant

 

National

Science & Technology

RSS

Scholarships

About us

International

Health

Twitter

Government Schemes

Feedback

Regional

History

Facebook

Education

Register

Politics

Opinion

Newsletter

Contact us

Business

The Funny Side

Education & Career

 

 

Ummid.com: Disclaimer | Terms of Use | Advertise with us | Link Exchange

Ummid.com is part of the Awaz Multimedia & Publications providing World News, News Analysis and Feature Articles on Education, Health. Politics, Technology, Sports, Entertainment, Industry etc. The articles or the views displayed on this website are for public information and in no way describe the editorial views. The users are entitled to use this site subject to the terms and conditions mentioned.

2012 Awaz Multimedia & Publications. All rights reserved.